Glycerol and reuterin-producing Limosilactobacillus reuteri enhance butyrate production and inhibit Enterobacteriaceae in broiler chicken cecal microbiota PolyFermS model - Asare, P. T.; Greppi, A.; Geirnaert, A.; Pennacchia, A.; Babst, A.; Lacroix, C. (BMC Microbiol, 2023)

High-resolution sample inference from Illumina amplicon data - Callahan, B. J.; McMurdie, P. J.; Rosen, M. J.; Han, A. W.; Johnson, A. J.; Holmes, S. P. (Nat Methods, 2016)

Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases - Cao, J.; Yu, Z.; Liu, W.; Zhao, J.; Zhang, H.; Zhai, Q.; Chen, W. (J Funct Foods, 2020)

Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides - Chia, L. W.; Mank, M.; Blijenberg, B.; Bongers, R. S.; Limpt, K.; Wopereis, H.; Tims, S.; Stahl, B.; Belzer, C.; Knol, J. (Benef Microbes, 2021)

Cell factories converting lactate and acetate to butyrate: Clostridium butyricum and microbial communities from dark fermentation bioreactors - Detman, A.; Mielecki, D.; Chojnacka, A.; Salamon, A.; Błaszczyk, M. K.; Sikora, A. (Microb Cell Fact, 2019)

Meta-analysis of gut microbiome studies identifies disease-specific and shared responses - Duvallet, C.; Gibbons, S. M.; Gurry, T.; Irizarry, R. A.; Alm, E. J. (Nat Commun, 2017)

Nutritional profile and cooking quality of a new functional pasta naturally enriched in phenolic acids, added with β-glucan and Bacillus coagulans GBI-30, 6086 - Fares, C.; Menga, V.; Martina, A.; Pellegrini, N.; Scazzina, F.; Torriani, S. (J Cereal Sci, 2015)

Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-induced colitis following vancomycin withdrawal in mice - Fitzpatrick, L. R.; Small, J. S.; Greene, W. H.; Karpa, K. D.; Farmer, S.; Keller, D. (Gut Pathog, 2012)

Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review - Ganji-Arjenaki, M.; Rafieian-Kopaei, M. (J Cell Physiol, 2018)

Review article: the role of butyrate on colonic function - Hamer, H. M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F. J.; Brummer, R. J. (Aliment Pharmacol Ther, 2008)

Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A (2017) Bifidobacteria and their health-promoting effects. Microbiol Spectr 5. https://doi.org/10.1128/microbiolspec.BAD-0010-2016

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic - Hill, C.; Guarner, F.; Reid, G.; Gibson, G. R.; Merenstein, D. J.; Pot, B.; Morelli, L.; Canani, R. B.; Flint, H. J.; Salminen, S.; Calder, P. C.; Sanders, M. E. (Nat Rev Gastroenterol Hepatol, 2014)

Acid and bile tolerance of spore-forming lactic acid bacteria - Hyronimus, B.; Marrec, C.; Sassi, A. H.; Deschamps, A. (Int J Food Microbiol, 2000)

Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota - Imase, K.; Takahashi, M.; Tanaka, A.; Tokunaga, K.; Sugano, H.; Tanaka, M.; Ishida, H.; Kamiya, S.; Takahashi, S. (Microbiol Immunol, 2008)

Simultaneous amelioratation of colitis and liver injury in mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27 - Jang, S. E.; Jeong, J. J.; Kim, J. K.; Han, M. J.; Kim, D. H. (Sci Rep, 2018)

The probiotic ID-JPL934, attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression - Je, I. G.; Lee, D. G.; Jeong, D. G.; Hong, D.; Yoon, J. M.; Moon, J. S.; Park, S. (J Med Food, 2018)

Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK (2020) Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 3:CD005573. https://doi.org/10.1002/14651858.CD005573.pub3

Spores of Bacillus coagulans GBI-30, 6086 show high germination survival and enzyme activity in a dynamic computer-controlled in vitro model of the gastrointestinal tract - Keller, D.; Verbruggen, S.; Cash, H.; Farmer, S.; Venema, K. (Benef Microbes, 2019)

Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies - Klindworth, A.; Pruesse, E.; Schweer, T.; Peplies, J.; Quast, C.; Horn, M.; Glöckner, F. O. (Nucleic Acids Res, 2013)

Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice - Kong, Q.; He, G. Q.; Jia, J. L.; Zhu, Q. L.; Ruan, H. (Curr Microbiol, 2011)

Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India - Kumari, R.; Ahuja, V.; Paul, J. (World J Gastroenterol, 2013)

Bacillus coagulans in combination with chitooligosaccharides regulates gut microbiota and ameliorates the DSS-induced colitis in mice - Liu, Z.; Jiang, Z.; Zhang, Z.; Liu, T.; Fan, Y.; Liu, T.; Peng, N. (Microbiol Spectr, 2022)

Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine - Louis, P.; Flint, H. J. (FEMS Microbiol Lett, 2009)

Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine - Maathuis, A. J.; Keller, D.; Farmer, S. (Benef Microbes, 2010)

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis - Machiels, K.; Joossens, M.; Sabino, J.; Preter, V.; Arijs, I.; Eeckhaut, V.; Ballet, V.; Claes, K.; Immerseel, F.; Verbeke, K.; Ferrante, M.; Verhaegen, J.; et al. (Gut, 2014)

Basic clinical study on Nakayama spore-forming lactic acid bacteria - Mashita, T.; Shimizu, K.; Ogasawara, M.; Nakajima, M. (J New Rem Clin, 1964)

Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria - Matsuki, T.; Watanabe, K.; Fujimoto, J.; Kado, Y.; Takada, T.; Matsumoto, K.; Tanaka, R. (Appl Environ Microbiol, 2004)

Gut microbiota in the pathogenesis of inflammatory bowel disease - Nishida, A.; Inoue, R.; Inatomi, O.; Bamba, S.; Naito, Y.; Andoh, A. (Clin J Gastroenterol, 2018)

Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases - Parada Venegas, D.; Fuente, M. K.; Landskron, G.; González, M. J.; Quera, R.; Dijkstra, G.; Harmsen, H. J. M.; Faber, K. N.; Hermoso, M. A. (Front Immunol, 2019)

Mechanisms of disease: inflammatory bowel diseases - Ramos, G. P.; Papadakis, K. A. (Mayo Clin Proc, 2019)

Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR - Rinttilä, T.; Kassinen, A.; Malinen, E.; Krogius, L.; Palva, A. (J Appl Microbiol, 2004)

Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG (2015) Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 362:fnv176. https://doi.org/10.1093/femsle/fnv176

Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 explain the bifidogenic and butyrogenic effects of arabinoxylan oligosaccharides - Rivière, A.; Gagnon, M.; Weckx, S.; Roy, D.; Vuyst, L. (Appl Environ Microbiol, 2015)

Rubin DT, Peyrin-Biroulet L, Reinisch W, Tole S, Sullivan L, Park KT, Regueiro M (2021) Inflammatory bowel disease patients’ perspectives of clinical trials: a global quantitative and qualitative analysis. Crohns Colitis 360 3:otab079. https://doi.org/10.1093/crocol/otab079

Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches - Sartor, R. B.; Wu, G. D. (Gastroenterology, 2017)

Low amounts of dietary fibre increase in vitro production of short-chain fatty acids without changing human colonic microbiota structure - Sasaki, D.; Sasaki, K.; Ikuta, N.; Yasuda, T.; Fukuda, I.; Kondo, A.; Osawa, R. (Sci Rep, 2018)

Construction of a model culture system of human colonic microbiota to detect decreased Lachnospiraceae abundance and butyrogenesis in the feces of ulcerative colitis patients - Sasaki, K.; Inoue, J.; Sasaki, D.; Hoshi, N.; Shirai, T.; Fukuda, I.; Azuma, T.; Kondo, A.; Osawa, R. (Biotechnol J, 2019)

Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota - Sasaki, K.; Sasaki, D.; Inoue, J.; Hoshi, N.; Maeda, T.; Yamada, R.; Kondo, A. (Appl Microbiol Biotechnol, 2020)

Effects of partially hydrolyzed guar gums of different molecular weights on a human intestinal in vitro fermentation model - Sasaki, D.; Sasaki, K.; Abe, A.; Ozeki, M.; Kondo, A. (J Biosci Bioeng, 2023)

Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model - Sato, T.; Matsumoto, K.; Okumura, T.; Yokoi, W.; Naito, E.; Yoshida, Y.; Nomoto, K.; Ito, M.; Sawada, H. (FEMS Microbiol Ecol, 2008)

Synbiotic supplementation containing whole plant sugar cane fibre and probiotic spores potentiates protective synergistic effects in mouse model of IBD - Shinde, T.; Perera, A. P.; Vemuri, R.; Gondalia, S. V.; Karpe, A. V.; Beale, D. J.; Shastri, S.; Southam, B.; Eri, R.; Stanley, R. (Nutrients, 2019)

In vitro human colon microbiota culture model for drug research - Shintani, T.; Sasaki, D.; Matsuki, Y.; Kondo, A. (Med Drug Discov, 2024)

Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3 - Talero, E.; Bolivar, S.; Ávila-Román, J.; Alcaide, A.; Fiorucci, S.; Motilva, V. (Inflamm Bowel Dis, 2015)

Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets - Tie, Y.; Huang, Y.; Chen, R.; Li, L.; Chen, M.; Zhang, S. (Gut Microbes, 2023)

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study - Tursi, A.; Brandimarte, G.; Papa, A.; Giglio, A.; Elisei, W.; Giorgetti, G. M.; Forti, G.; Morini, S.; Hassan, C.; Pistoia, M. A.; Modeo, M. E.; Rodino', S.; et al. (Am J Gastroenterol, 2010)

Ulcerative colitis - Ungaro, R.; Mehandru, S.; Allen, P. B.; Peyrin-Biroulet, L.; Colombel, J. F. (Lancet, 2017)

The usefulness of microencapsulated sodium butyrate add-on therapy in maintaining remission in patients with ulcerative colitis: a prospective observational study - Vernero, M.; Blasio, F.; Ribaldone, D. G.; Bugianesi, E.; Pellicano, R.; Saracco, G. M.; Astegiano, M.; Caviglia, G. P. (J Clin Med, 2020)

Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function - Wang, Y.; Xie, Q.; Zhang, Y.; Ma, W.; Ning, K.; Xiang, J. Y.; Cui, J.; Xiang, H. (Appl Microbiol Biotechnol, 2020)

Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis - Yamada, T.; Hino, S.; Iijima, H.; Genda, T.; Aoki, R.; Nagata, R.; Han, K. H.; Hirota, M.; Kinashi, Y.; Oguchi, H.; Suda, W.; Furusawa, Y.; et al. (EBioMedicine, 2019)

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis - Yoshimatsu, Y.; Yamada, A.; Furukawa, R.; Sono, K.; Osamura, A.; Nakamura, K.; Aoki, H.; Tsuda, Y.; Hosoe, N.; Takada, N.; Suzuki, Y. (World J Gastroenterol, 2015)

Lactate cross-feeding between Bifidobacterium species and Megasphaera indica contributes to butyrate formation in the human colonic environment - Zhao, S.; Lau, R.; Zhong, Y.; Chen, M. H. (Appl Environ Microbiol, 2024)